Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survival.
Leichman L, Lawrence D, Leichman CG, Nava H, Nava E, Proulx G, Clark K, Khushalani NI, Berdzik J, Greco W, Smith P, Creaven PJ, Kepner JL, Javle MM, Pendyala L. Leichman L, et al. Among authors: pendyala l. J Chemother. 2006 Oct;18(5):514-24. doi: 10.1179/joc.2006.18.5.514. J Chemother. 2006. PMID: 17127229 Clinical Trial.
Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer.
Khushalani NI, Leichman CG, Proulx G, Nava H, Bodnar L, Klippenstein D, Litwin A, Smith J, Nava E, Pendyala L, Smith P, Greco W, Berdzik J, Douglass H, Leichman L. Khushalani NI, et al. Among authors: pendyala l. J Clin Oncol. 2002 Jun 15;20(12):2844-50. doi: 10.1200/JCO.2002.12.032. J Clin Oncol. 2002. PMID: 12065561 Clinical Trial.
Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells.
Varma R, Hector S, Greco WR, Clark K, Hawthorn L, Porter C, Pendyala L. Varma R, et al. Among authors: pendyala l. Cancer Chemother Pharmacol. 2007 May;59(6):711-23. doi: 10.1007/s00280-006-0325-3. Epub 2006 Sep 22. Cancer Chemother Pharmacol. 2007. PMID: 17021820
S-phase modulation by irinotecan: pilot studies in advanced solid tumors.
Ramnath N, Khushalani N, Toth K, Litwin AM, Intengan ME, Slocum HK, Pendyala L, Smith PF, Stewart CC, Hoffman JL, Javle MM, Berdzik J, Creaven PJ, Rustum YM. Ramnath N, et al. Among authors: pendyala l. Cancer Chemother Pharmacol. 2005 Nov;56(5):447-54. doi: 10.1007/s00280-004-0951-6. Epub 2005 Jun 10. Cancer Chemother Pharmacol. 2005. PMID: 15947933 Clinical Trial.
142 results